Showing results 1 to 1 of 1
| Issue Date | Title | Journal Title |
|---|---|---|
| 2025 | A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial | ANNALS OF ONCOLOGY |